Tags: Autism | autism | drug | tested | high-functioning

New Autism Drug Being Tested Worldwide

New Autism Drug Being Tested Worldwide
(Copyright DPC)

Wednesday, 04 April 2018 03:20 PM

A first-of-a-kind autism drug is being tested in a U.S.-wide clinical trial that includes 300 children and teens with high functioning autism.

Researchers are assessing if the drug, balovaptan, can help improve social behavior in youngsters with autism. Previous research found that the drug helped adults with autism, CBS News reported.

"There are not any approved treatments for what we think of as the core symptoms of autism all of the social difficulties, repetitive behaviors and the ability to function in everyday life," said Dr. Eric Hollander, director, Autism and Obsessive-Compulsive Spectrum Program, Montefiore Medical Center in the Bronx.

Even if it's effective, the new drug would be just one part of treatment, he noted.

"There would still be need for speech therapy, occupational therapy, educational interventions, behavioral interventions," Hollander told CBS News.

There is no cure for autism, which affects 1 in 68 children in the U.S., according to the Centers for Disease Control and Prevention.

© HealthDay

   
1Like our page
2Share
Health-News
A first-of-a-kind autism drug is being tested in a U.S.-wide clinical trial that includes 300 children and teens with high functioning autism.Researchers are assessing if the drug, balovaptan, can help improve social behavior in youngsters with autism. Previous research...
autism, drug, tested, high-functioning
157
2018-20-04
Wednesday, 04 April 2018 03:20 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved